Literature DB >> 12640563

Blood-induced joint damage in hemophilia.

Goris Roosendaal1, Floris P J G Lafeber.   

Abstract

Hemophilia is a X chromosome-linked disease characterized by an increased tendency to hemorrhage. Because of recurrent hemarthrosis, specific changes occur in synovium and cartilage. This process is called hemophilic arthropathy. The pathogenetic mechanisms involved are not precisely known. Current concepts, which are based on experimental in vitro studies and clinical experience, hold that the synovium becomes catabolically active because of the exposure to blood components and as a result induces cartilage destruction. A considerable number of reports concerning blood-induced joint damage suggest that synovial changes have a leading role in the development of the joint damage and therefore precede the changes in cartilage. However, there are also observations that question whether this is the only and initiating mechanism of joint damage in hemophilia. These observers hold that intra-articular blood has a direct harmful effect on cartilage before synovial changes and suggest that joint damage may occur before synovial inflammation is evident. Primarily, there may be damage of articular cartilage with synovitis as a consequence. Some studies show that synovitis is involved but that it is not the only mechanism in the joint damage caused by intra-articular bleeding. These findings do not contradict the current concept of blood-induced cartilage damage in which synovial changes are thought to play an important role. Several pathological processes are possibly involved, some of them occurring in parallel and others sequentially. Possibly, intra-articular blood first has a direct effect on cartilage, and then it affects the synovium. Thus, both processes occur in parallel, and although they influence each other they probably do not depend on each other. This concept resembles degenerative joint damage as found in osteoarthritis.

Entities:  

Mesh:

Year:  2003        PMID: 12640563     DOI: 10.1055/s-2003-37938

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  22 in total

1.  Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

Authors:  Christos Tsoukas; M Elaine Eyster; Sumiko Shingo; Saurabh Mukhopadhyay; Karen M Giallella; Sean P Curtis; Alise S Reicin; Agustin Melian
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

2.  The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.

Authors:  Sweta Gupta; Azfar-E-Alam Siddiqi; J Michael Soucie; Marilyn Manco-Johnson; Roshni Kulkarni; Heidi Lane; Robina Ingram-Rich; Joan C Gill
Journal:  Br J Haematol       Date:  2013-02-22       Impact factor: 6.998

Review 3.  Mass spectrometry imaging: a novel technology in rheumatology.

Authors:  Beatriz Rocha; Cristina Ruiz-Romero; Francisco J Blanco
Journal:  Nat Rev Rheumatol       Date:  2016-11-24       Impact factor: 20.543

Review 4.  Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.

Authors:  Alisa S Wolberg; Maria M Aleman; Karin Leiderman; Kellie R Machlus
Journal:  Anesth Analg       Date:  2011-11-21       Impact factor: 5.108

5.  Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A.

Authors:  Atsushi Muto; Kazutaka Yoshihashi; Minako Takeda; Takehisa Kitazawa; Tetsuhiro Soeda; Tomoyuki Igawa; Zenjiro Sampei; Taichi Kuramochi; Akihisa Sakamoto; Kenta Haraya; Kenji Adachi; Yoshiki Kawabe; Keiji Nogami; Midori Shima; Kunihiro Hattori
Journal:  Blood       Date:  2014-10-01       Impact factor: 22.113

6.  Blood exposure has a negative effect on engineered cartilage.

Authors:  C Sosio; F Boschetti; L Mangiavini; C Scotti; S Manzotti; M S Buragas; S Biressi; G Fraschini; A Gigante; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-10-28       Impact factor: 4.342

Review 7.  Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.

Authors:  Hans-Christoph Rossbach
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

8.  A long term results of external beam radiation therapy in hemophilic arthropathy of the ankle in children.

Authors:  Moonkyoo Kong; Jin Oh Kang; Jinhyun Choi; Seo Hyun Park
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

9.  Effect of blood on the morphological, biochemical and biomechanical properties of engineered cartilage.

Authors:  C Sosio; F Boschetti; C Bevilacqua; L Mangiavini; C Scotti; M S Buragas; S Biressi; G Fraschini; A Gigante; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-05-12       Impact factor: 4.342

10.  Components in Plasma-Derived Factor VIII, But Not in Recombinant Factor VIII Downregulate Anti-Inflammatory Surface Marker CD163 in Human Macrophages through Release of CXCL4 (Platelet Factor 4).

Authors:  Anne Bertling; Martin F Brodde; Mayken Visser; Janina Treffon; Michelle Fennen; Anke C Fender; Reinhard Kelsch; Beate E Kehrel
Journal:  Transfus Med Hemother       Date:  2017-08-11       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.